Pfizer PFE.
A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.
Good things come in threes. Here are three solid stocks in three different industries with greate.
Sep 19 2017 • Fool.com.
On the hunt for a fat dividend yield? These three big pharma stocks deliver.
Sep 19 2017 • Fool.com.
GlaxoSmithKline, HCP, and Pfizer all offer their shareholders fat payouts. Here's why income inve.
Sep 18 2017 • Fool.com.
It's a tough decision between these two big pharma stocks.
Sep 17 2017 • Fool.com.
These stocks should stand the test of time.
Sep 16 2017 • Fool.com.
The two companies are battling to expand the use of their cancer drugs in prostate-cancer patients.
Sep 15 2017 • Fool.com.
An announcement from Allergan of a novel way to defend against patent challenges could be just wh.
Sep 11 2017 • Fool.com.
Why AT&T, Intel, and Pfizer look like great stocks for retired investors.
Sep 7 2017 • Fool.com.
Big pharma stands to make hundreds of billions of dollars from a handful of medical conditions.
Sep 6 2017 • Fool.com.
How do Eli Lilly and Pfizer fare in a head-to-head matchup between the two big pharma stocks?
Sep 1 2017 • Fool.com.
Investing always seems to incur costs, but Darden Restaurants, MasterCard, and Pfizer actually pa.
Sep 1 2017 • Fool.com.
Why AbbVie, Pfizer, and Sanofi are three of the top high-yield healthcare stocks to be found.
Aug 29 2017 • Fool.com.
If you're looking to add high-quality, low-volatility income stocks to your portfolio, these are .
Aug 28 2017 • Fool.com.
Roche, Novartis, Pfizer, Johnson & Johnson, and Merck are investing the heaviest in R&D. That cou.
Aug 27 2017 • Fool.com.
Pfizer and Amgen are encountering problems getting traction for their biosimilars. Is the system .
Aug 26 2017 • Fool.com.
These rare gems offer both a high yield and an acceptable level of risk.
Aug 23 2017 • Fool.com.
Pfizer, GlaxoSmithKline, and Novo Nordisk all offer up temptingly high yields. Here's why they're.
Aug 22 2017 • Fool.com.
There's good reason why Pfizer, Cisco Systems, and Diageo can work for you in your retirement.
Aug 21 2017 • Fool.com.
Besponsa's FDA approval for use in some leukemia patients continues to position the company as a .
Aug 20 2017 • Fool.com.
Pfizer's last 40 years show what it takes to become a millionaire: Buy, hold, and reinvest.
Aug 20 2017 • Fool.com.
Looking for income from the healthcare sector? Here's why you should check out GlaxoSmithKline, P.
Aug 10 2017 • Fool.com.
With U.S. lawmakers failing to tackle corporate tax reform, Pfizer's appetite for a large-scale a.
Aug 2 2017 • Fool.com.
Sure, Pfizer's revenue dropped in Q2, but here are a dozen numbers that matter more.
Aug 1 2017 • Fool.com.
Here's what to look for when Pfizer announces its Q2 results on Aug. 1.
Jul 30 2017 • Fool.com.
These brand-name companies offer income and value potential that can't be ignored.
Jul 28 2017 • Fool.com.
PFE stock quote.
Stock Performance.
Key Data Points.
Company Rating.
How do you think Pfizer will perform against the market?
Modal Outperform.
Modal Underperform.
You pick for Pfizer is winning.
CEO Rating.
Based on 832 Ratings.
Business Summary.
A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.
© 1995 – 2017 The Motley Fool. All rights reserved.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS BZX. Market data provided by FactSet.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.